Gutenberg Test Page - Lustgarten Foundation: Pancreatic Cancer Research

Gutenberg Test Page

Led By Lustgarten: How Research Impacts Care

November is Pancreatic Cancer Awareness Month Join us at Noon, Tuesday, Nov. 9 for a special event: Led By Lustgarten: How Research Impacts Patient Care featuring Dr. Joseph Herman, Vice Chair of Clinical Informatics for Radiation Medicine and Director of Clinical Research Integration at Northwell Health. A nationally-recognized radation oncologist, Dr. Herman will sit down with Lustgarten CEO Linda Tantawi and VP of Research Dr. Andrew Rakeman for a live, interactive conversation on how Lustgarten-funded research informs patient treatment in the care setting. Register now to save your seat!

Learn More

Long Island Walk a Success

More than 2,000 Long Islanders touched by pancreatic cancer were finally able to come back together at Jones Beach in Wantagh on Sunday, Oct. 3 for a day of hope, awareness and fundraising for pancreatic cancer research. The Lustgarten Foundation’s annual Walk for Pancreatic Cancer Research marked the Foundation’s first in-person event on Long Island in more than a year since the COVID-19 pandemic halted gatherings. Supporters rose to the occasion by raising more than $650,000 and catapulting the 21-year total to over $18 million, with 100% of every dollar raised funding life-saving research.  “We believe community is power,” said Linda Tantawi, Lustgarten CEO. “Pancreatic cancer is a devasting disease, so it is especially important for survivors, patients, family, friends, researchers and healthcare providers to have a place to come together to remember those we have lost, to honor those in the fight and to take positive action against the disease. We also believe research is fundamental to transforming pancreatic cancer into a curable disease. Thanks to the incredible support of this event over the years, the Lustgarten Foundation is the largest private funder of pancreatic cancer research in the world, able to support bold and innovative research.” 

Learn More

Juneteenth Webinar:
Meet Dr. Posey

Pancreatic cancer is a uniquely challenging disease, requiring bold and innovative science. We know these challenges are even greater for Black people and African Americans, who experience both higher incidence and death rates than other populations.
Avery D. Posey, PhD, knows the statistic well–both as an African American scientist and a patient family member. Dr. Posey is the inaugural recipient of the Lustgarten Foundation Career Development Grant honoring Congressman John R. Lewis. He will discuss the importance of diversity within the field of pancreatic cancer research and the need for more BIPOCx participants in clinical trials. Made possible in part through the support of Bristol Myers Squibb, this Juneteenth webinar is part of the Lustgarten Foundation’s recognition of National Black Family Cancer Awareness Week June 17-23. Created by the U.S. Food & Drug Administration’s Oncology Center of Excellence, Black Family Cancer Week is designed to increase cancer awareness in one of the most vulnerable segments of the US population. #BlackFamCan This webinar is made possible in part through the support of Bristol Myers Squibb.

Learn More

In Person Walks
Are Back!

Join Hundreds of Walkers and Runners Across New York on June 27th  in the Critical Fight Against Pancreatic Cancer. The Lustgarten Foundation’s New York Walk Series is your chance to join forces with hundreds of others whose lives have been touched by pancreatic cancer. Together we will raise the critical funds and awareness needed to defeat this this devastating disease. Register. Donate. Fundraise. Walk where you want, when you want in your neighborhood. 100% of all donations fund lifesaving pancreatic cancer research. Whether you walk with us in New York City or walk in your own neighborhood, your action will change lives and inspire others! Choose an event near you and join our community of patients, survivors and loved ones coming together to celebrate, reflect and remember as we move closer to a cure for pancreatic cancer. Your Walk for Research will leave you energized and optimistic about the future. Together, we will defeat this disease!

Learn More


The wait is over to get your LUSTGARTEN LOOT! Our first-ever online store is now LIVE. Shop all of our great Lustgarten merchandise, from tumblers to T-shirts to a cozy and versatile 4-in-1 blanket. We have something for everyone—even your four-legged friends! All proceeds fund pancreatic cancer research, so start shopping today!

Learn More

Give 5X the Hope
this Mother’s Day

In recognition of Mother’s Day, and in honor of Barbara, Stephanie and all women impacted by pancreatic cancer, please give your most generous gift todayNow through midnight on Mother’s Day—Sunday, May 9—your donation will be matched 5x up to $35,000*, thanks to Stephanie Kessler and Laura Hull, who also lost her mom to pancreatic cancer. That means every $1 becomes $5, and 100% of every donation funds life-saving pancreatic cancer research! Please give today!

Learn More

Career Development Awards Announced

The inaugural winners of the Lustgarten Foundation-AACR Career Development Awards for Pancreatic Cancer Research in Honor of Ruth Bader Ginsburg and John Robert Lewis were announced at the 2021 AACR annual meeting. For Dr. Avery Posey it was a bout with chickenpox when he was in 4th grade that spurred his interest in science. He was quarantined in one room for about a week and still remembers his grandmother lovingly applying calamine lotion to his blisters. “I was miserable, itchy, missed school, missed my friends, and all I kept thinking was there had to be a way to prevent this,” Posey says. A few years later, the chickenpox vaccine was unveiled and “most kids today don’t even know what chickenpox is,” he continues. “I thought for a while I wanted to be a doctor, but I realized in undergraduate school that real important changes in how we look at disease and treat disease is due to research.” Dr. Dannielle Engle thought she was going to be a violinist, a virtuoso maybe along the lines of Joshua Bell. She started college majoring in music, but switched gears and wound up majoring in biology. When she took a low-level job in a research lab while still an undergrad, it was the fruit fly and its simple genetic structure as well as the creativity shown by the investigators with whom she worked that made her realize science was her calling. “I was a pretty good violinist, not great,” she laughs. “But I got completely hooked on my work in the lab and I knew at that point my future was in research.”

Learn More

International Pancreatic Cancer Trial opens

 Researchers testing organoids use in predicting treatment outcomes

A new team of pioneering pancreatic cancer researchers has been formed to predict which treatments might work best for individual pancreatic cancer patients based on the molecular traits of tumors. The Pancreatic Cancer Convergence Dream Team is funded by the Pancreatic Cancer Collective, an initiative of the Lustgarten Foundation and Stand Up To Cancer® (SU2C), SU2C Canada and Pancreatic Cancer Canada. The team will be led by Jennifer Knox, MD, the Lewitt Chair in Pancreatic Cancer Research at the Princess Margaret Cancer Centre, part of University Health Network, and professor of medicine at the University of Toronto in Canada, and Elizabeth Jaffee, MD, a professor of oncology and deputy director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, Maryland.

Learn More

Remembering Stephen Grand

Stephen Grand: Pancreatic Cancer Fighter and Research Funder

Our hearts are broken at the news of the passing of Lustgarten ally and donor, Stephen Grand of Belvedere, CA. A passionate and insightful philanthropist, as well as a pancreatic cancer patient, Steve was in the unique position of understanding the urgency of moving the research along quickly and the need to invest in the most innovative science with the greatest opportunity to drive real progress. Tomorrow is promised to no one, but Steve’s hope was that through his philanthropy pancreatic patients like himself would someday be promised more time.

Learn More

Register For Lustgarten Live!

Welcome to LustgartenLIVE! a quarterly series of webinars designed to bring you face-to-face with the best researchers investigating pancreatic cancer. Moderated by Andrew Rakeman, PhD , Vice President of Research, each webinar in the series will focus on a different aspect of the research funded through your donations. REGISTRATION IS NOW OPEN for The Best of 2021: Research Highlights
The Best of 2021: Research Highlights, the final LustgartenLIVE! in the inaugural quarterly series, will stream at Noon, Tuesday, Dec. 14. LustgartenLIVE! was created to give patients, family members, donors and others an opportunity to hear directly from the lead scientists behind our most promising research projects in earlier detection, drug development and personalized medicine. And, because it’s LIVE, you’ll have an opportunity to ask them questions. The Best of 2021: Research Highlights presenters include: David Tuveson, MD, PhD Chief Scientist; Director of the Lustgarten Foundation Dedicated Research Lab at Cold Spring Harbor Laboratory (CSHL) Cancer Center; President, American Association of Cancer Research (AACR) Elizabeth Jaffee, MD Chief Medical Advisor; Director, Lustgarten Clinical Accelerator Initiative; Deputy Director of the Sidney Kimmel Comprehensive Cancer Center and Co-director of the Skip Viragh Center for Pancreas Cancer Clinical Research and Patient Care at the Johns Hopkins University School of Medicine Linda Tantawi CEO, Lustgarten Foundation Andrew Rakeman, PhD VP of Research, Lustgarten Foundation

Learn More

Pancreatic Cancer News

How diet affects tumors

22. 10. 21 Glen Peck
A new study finds cutting off cells’ supplies of lipids can slow the growth of tumors in mice. In recent years, there has been some evidence that dietary interventions can help to slow the growth of tumors. A new study from MIT, which analyzed two different diets in mice, reveals how those diets affect cancer […]

Pancreatic cancer clinical trials exclude Black patients based on wide range of eligibility criteria

7. 10. 21 Glen Peck
A simulated pancreatic cancer clinical trial screening process showed that Black patients were significantly more likely than white patients to be excluded from clinical trials for a wide range of eligibility criteria, according to results presented at the virtual 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically […]

The Power of Therapeutic Laughter

1. 10. 21 Glen Peck
When you’re facing a pancreatic cancer diagnosis, humor may be tough to come by. Instead, feelings of grief, sadness, depression and anxiety become so all-consuming that getting a chuckle from even the most hilarious prank seems like an impossibility. But here’s the thing: It turns out that laughter — whether forced or spontaneous — is […]

A Leading Surgeon Helps Patients with Pancreatic Cancer Overcome Steep Odds

1. 10. 21 Glen Peck
An internationally renowned pancreatic surgeon, surgical oncologist, and cancer researcher, Christopher Wolfgang, MD, PhD, joined NYU Langone Health last January. He is chief of the new Division of Hepatobiliary and Pancreatic Surgery in the Department of Surgery, having previously served as chief of hepatobiliary and pancreatic surgery and vice chair for surgical oncology at Johns […]

Pancreatic Cancer Research Ramps Up as Roche and NovoCure Announce Partnership

1. 10. 21 Glen Peck
Pancreatic cancer has the lowest survival rate of the most common cancers, less than 10% of patients survive longer than five years, largely due to most cases being diagnosed at a late stage. A collaboration between NovoCure and Roche hopes to improve those odds. This morning, NovoCure and Swiss pharma giant Roche announced a collaboration […]

Unique Aspects of Pancreatic Cancer Proteins Could Lead to Early Detection, New Treatments

1. 10. 21 Glen Peck
Newswise — A large international collaboration led by researchers from the Johns Hopkins Kimmel Cancer Center has identified promising new targets for pancreatic cancer treatment and early diagnosis after examining various aspects of these tumors’ genes and proteins. Their findings, published online Sept. 16 in Cell, could offer hope to patients with this deadly disease. […]

13 Warning Signs of Pancreatic Cancer You Should Know, Doctors Say

1. 10. 21 Glen Peck
Pancreatic cancer is tricky to identify. In the early stages, there might not be much—if any—indication something is even wrong, and that’s exactly why doctors often refer to it as a “silent killer.” Most recently, the deadly disease took the life of actor Willie Garson. Best known for his role as Stanford Blatch on Sex […]

Why Identical Genetic Mutations Cause Different Types of Cancer

19. 7. 21 ladmin
Why do alterations of certain genes cause cancer only in specific organs of the human body? Scientists at the German Cancer Consortium (DKTK), the Technical University of Munich (TUM), and the University Medical Center Göttingen have now demonstrated that cells originating from different organs are differentially susceptible to activating mutations in cancer drivers: The same […]

Matchmakers: How Basket Trials Match Patients With Drugs Based on Their Tumors

14. 7. 21 ladmin
Drew Huggins was running out of options. After his diagnosis of metastatic pancreatic cancer two years ago, at age 47, he hadn’t had any luck with the treatments he’d tried so far. His tumors didn’t respond to 13 cycles of FOLFIRINOX, an arduous four-drug chemotherapy combination. The chemo- therapy combination of gemcitabine and paclitaxel didn’t […]

Get Involved Today

Get inspired and connect with patients, survivors and loved ones who are all on the same journey.

Back to Top